Hemodynamic and Cardiac Effects of the Selective T-Type and L-Type Calcium Channel Blocking Agent Mibefradil in Patients With Varying Degrees of Left Ventricular Systolic Dysfunction
- 31 October 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 28 (4) , 972-979
- https://doi.org/10.1016/s0735-1097(96)00261-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effect of Mibefradil on Left Ventricular Diastolic Function in Patients with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1996
- Long‐Term Survival and Use of Antihypertensive Medications in Older PersonsJournal of the American Geriatrics Society, 1995
- NifedipineCirculation, 1995
- Selective inhibition of T-type Ca2+ channels by Ro 40-5967.Circulation Research, 1994
- Lack of Negative Inotropic Effects of the New Calcium Antagonist Ro 40–5967 in Patients with Stable Angina PectorisJournal of Cardiovascular Pharmacology, 1991
- Ro 40–5967: A New Nondihydropyridine Calcium AntagonistCardiovascular Drug Reviews, 1991
- Classes of Calcium Channels in Vertebrate CellsAnnual Review of Physiology, 1989
- Prognostic importance of the immediate hemodynamic response to nifedipine in patients with severe left ventricular dysfunctionJournal of the American College of Cardiology, 1987
- Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.Circulation, 1987
- Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectorisThe American Journal of Cardiology, 1984